Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept plus Micropulse Laser for Diabetic Macular Edema
NCT04014556Completed
- Sponsor
- Alexandria University
- Start
- Apr 2016
- Primary completion
- Oct 2018
01
Overview
Randomised, open-label trial (2 arms), sponsored by Alexandria University. Primary endpoint: The number of Aflibercept injections in both groups at 12 months. Started Apr 2016; status: completed.
Beyond the preview
Go deeper on NCT04014556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04014556.